Raleigh, NC, United States of America

Neil Buckley

This inventor holds 3 USPTO granted patents. Top assignees: Athenen Therapeutics, Inc., Eliem Therapeutics (UK) Ltd, Eliem Therapeutics, Inc.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Buckley. Retrieved from https://idiyas.com/inventor/neil-buckley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Boston, MA (US) (2020)
  • Raleigh, NC (US) (2021 - 2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Certainly! Here's the article about inventor Neil Buckley:

Title: Unveiling the Innovations of Neil Buckley: A Glimpse into Cutting-Edge Neurosteroid Compositions

Introduction:

Neil Buckley, a distinguished inventor based in Raleigh, NC (US), has made significant contributions to the field of neurosteroid compositions, particularly in the realm of GABAreceptor modulation. With a portfolio encompassing 3 patents, Buckley's work stands at the forefront of advancements in neuropharmacology.

Latest Patents:

One of Buckley's latest patents includes groundbreaking compositions that preferentially potentiate subtypes of GABAreceptors, allowing for the selective modulation of specific receptor subtypes. These neurosteroid-based compositions offer novel methods for treating GABAdisorders, showcasing Buckley's innovative approach to neuropharmacological interventions.

Career Highlights:

Having worked with esteemed companies such as Eliem Therapeutics, Inc. and Athenen Therapeutics, Inc., Neil Buckley has honed his expertise in developing cutting-edge pharmaceutical solutions. His commitment to pushing the boundaries of neuropharmacology is exemplified through his patent portfolio and industry collaborations.

Collaborations:

Throughout his career, Buckley has collaborated with various industry experts, including his coworker Andrew D Levin. Together, they have contributed to the advancement of neurosteroid research, paving the way for novel therapeutic interventions in the realm of GABAreceptor modulation.

Conclusion:

In conclusion, Neil Buckley's innovative work in neurosteroid compositions and GABAreceptor modulation underscores his dedication to pioneering advancements in neuropharmacology. His patents reflect a commitment to improving treatment modalities for GABAdisorders, solidifying his position as a visionary inventor in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…